Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
about
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileBlood Glucose Awareness Training in Dutch Type 1 diabetes patients. Short-term evaluation of individual and group trainingOvernight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesClinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.Measures of Risk and Glucose Variability in Adults Versus Youths.Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes MellitusAbnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness.Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome.GoCARB in the Context of an Artificial Pancreas.Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetesSafety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreasThe university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control.Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system.Effect of automated bio-behavioral feedback on the control of type 1 diabetes.Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulation.Neurocognitive Differences Between Drivers with Type 1 Diabetes with and without a Recent History of Recurrent Driving Mishaps.Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.Diabetes: Models, Signals, and Control.Hypoglycemia detection and prediction using continuous glucose monitoring-a study on hypoglycemic clamp dataThe median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus.A model of self-treatment behavior, glucose variability, and hypoglycemia-associated autonomic failure in type 1 diabetes.Examining the Behaviour subscale of the Hypoglycaemia Fear Survey: an international study.Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial datasetMetrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyDesign and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas.Fetal risk assessment in pregnancies complicated by diabetes mellitusTranslation of personalized decision support into routine diabetes care.Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 Randomized TrialDevelopment of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parametersUtility of different glycemic control metrics for optimizing management of diabetesEvidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Average Daily Risk Range (ADRR) in Young Children With Type 1 Diabetes.
P2860
Q27307805-A1FD7D34-9E10-4878-A339-BE6E7A01620DQ27687563-12916C04-C6A4-4F19-8AC0-FA990814D1B8Q28204601-19E9724D-AAE8-4975-9434-0D872A6B97E3Q28741005-EF58DF1F-6343-401D-89A4-D4E40361C300Q30252233-1144995E-78E6-4E9E-BFA1-68B559661A4BQ30252932-8FB7C99B-C0D1-4209-B079-D1446EF550B1Q30276764-EA2DCBB8-D0DF-419A-9AEA-379953277171Q30278730-B12E9AB1-8BF5-44A3-B0AD-28F09E78A4A1Q30278855-549A8406-E927-42AB-A374-756684443F44Q30279181-E174A6B6-70FC-4C36-A9BA-92EF3C1D8799Q30310690-BFD3B370-A5EB-45E7-8FF4-381E50DE091CQ30311149-5CB0E4F3-348A-406A-BA61-AC8E4E066926Q30359532-6BC85967-D9CA-4D98-8B9E-4CA46935D1E5Q30371583-76F6C241-C06A-46ED-93DB-56D2FDBB157DQ30384396-A504D008-4489-428D-BBEF-C115EFD8DE7DQ30384405-1ADDB7EA-F60C-43F5-82F5-91A8F0F53DB1Q30415517-472F5B43-88DF-4584-B148-0686BEB6067AQ30416241-BB13B1AE-B8E9-4BF7-B68D-0C70308C7D04Q30424301-753FC374-2007-4C21-8794-2D029298ABEEQ30428508-A435D5DD-569D-476A-BE57-5201A56CE169Q30429055-111FACA1-EC91-40E6-98FB-9226755DA152Q30431254-C96E5CEF-FBE4-4AFA-8683-1AB05441EAA9Q30434101-09073178-1B26-4D36-8660-174272C96378Q30434551-354353EC-6FB1-4F54-B25A-0EF92FBD1DEFQ30438000-BFFDD6F0-6CF6-47B6-BF22-6C24F0F3945AQ30438605-A0ECB3D2-9B91-44C4-ADE0-2621CAABE8E3Q30439212-5980702E-35DF-422D-8715-A5683DE2DACFQ30456407-C6A5C4EF-0DEB-4117-B556-46B45B163C9DQ30498210-4AD49EB7-9802-413F-813E-A490AAD0C054Q33727475-41F065A0-12BE-4C26-BA6F-410E5B8140C4Q34073479-19D647FC-8E86-469C-96A0-E54460E76292Q34194737-6D087115-1B06-46C5-93D7-043B5043286CQ34245943-ACC0A938-CB87-479B-B38E-1E4FF831CC5FQ34419973-9D529190-86C3-49EA-AC01-F30507F2214AQ34420058-C03E12A7-0669-4627-BC70-A30314CA62E0Q34506911-D2445B5F-E108-42B7-8519-15DC369B9EE8Q34812164-A63B5407-C78B-465C-809A-AE4059268B58Q35049855-0B18FA0C-3C28-4922-88E3-09E850C1EE21Q35630711-3BC2511B-0BE8-4C42-85C7-F01246CB40CBQ35679067-66826AF7-A219-4EB0-AF38-6D90694CCECB
P2860
Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Assessment of risk for severe ...... f the low blood glucose index.
@ast
Assessment of risk for severe ...... f the low blood glucose index.
@en
type
label
Assessment of risk for severe ...... f the low blood glucose index.
@ast
Assessment of risk for severe ...... f the low blood glucose index.
@en
prefLabel
Assessment of risk for severe ...... f the low blood glucose index.
@ast
Assessment of risk for severe ...... f the low blood glucose index.
@en
P2093
P1433
P1476
Assessment of risk for severe ...... f the low blood glucose index.
@en
P2093
Gonder-Frederick LA
Kovatchev BP
Schlundt D
Young-Hyman D
P304
P356
10.2337/DIACARE.21.11.1870
P407
P577
1998-11-01T00:00:00Z